Arkolith/Insider Trading/SLNO/Form 4

Anish Bhatnagar

CHIEF EXECUTIVE OFFICER, DirectorSOLENO THERAPEUTICS INC (SLNO) · full profile →Form 4 · filed Dec 17, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 15, 2025Tax withholding(F)8K$49.95$381K569K
Dec 15, 2025Gift(G)100K—$0469K

Transaction Codes

F
Shares withheld for taxes
G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001614821-25-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML